Introduction: Despite knowledge on the molecular basis of amyotrophic lateral sclerosis (ALS) having quickly progressed over the last few years, such discoveries have not yet translated into new therapeutics. With the advancement of stem cell technologies there is hope for stem cell therapeutics as novel treatments for ALS.Areas covered: We discuss in detail the therapeutic potential of different types of stem cells in preclinical and clinical works. Moreover, we address many open questions in clinical translation.Expert opinion: SC therapy is a potentially promising new treatment for ALS and the need to better understand how to develop cell-based experimental treatments, and how to implement them in clinical trials, becomes more pressing. Mesenchymal stem cells and neural fetal stem cells have emerged as safe and potentially effective cell types, but there is a need to carry out appropriately designed experimental studies to verify their long-term safety and possibly efficacy. Moreover, the cost-benefit analysis of the results must take into account the quality of life of the patients as a major end point. It is our opinion that a multicenter international clinical program aime d at fine-tuning and coordinating transplantation procedures and protocols is mandatory.

Mazzini, L., Vescovi, A., Cantello, R., Gelati, M., Vercelli, A. (2016). Stem cells therapy for ALS. EXPERT OPINION ON BIOLOGICAL THERAPY, 16(2), 187-199 [10.1517/14712598.2016.1116516].

Stem cells therapy for ALS

Vescovi, A;
2016

Abstract

Introduction: Despite knowledge on the molecular basis of amyotrophic lateral sclerosis (ALS) having quickly progressed over the last few years, such discoveries have not yet translated into new therapeutics. With the advancement of stem cell technologies there is hope for stem cell therapeutics as novel treatments for ALS.Areas covered: We discuss in detail the therapeutic potential of different types of stem cells in preclinical and clinical works. Moreover, we address many open questions in clinical translation.Expert opinion: SC therapy is a potentially promising new treatment for ALS and the need to better understand how to develop cell-based experimental treatments, and how to implement them in clinical trials, becomes more pressing. Mesenchymal stem cells and neural fetal stem cells have emerged as safe and potentially effective cell types, but there is a need to carry out appropriately designed experimental studies to verify their long-term safety and possibly efficacy. Moreover, the cost-benefit analysis of the results must take into account the quality of life of the patients as a major end point. It is our opinion that a multicenter international clinical program aime d at fine-tuning and coordinating transplantation procedures and protocols is mandatory.
Articolo in rivista - Articolo scientifico
Amyotrophic lateral sclerosis; Neuroinflammation; Neuroprotection; Stem cell;
Amyotrophic lateral sclerosis; Neuroinflammation; Neuroprotection; Stem cell; Amyotrophic Lateral Sclerosis; Animals; Clinical Trials as Topic; Genetic Therapy; Humans; Inflammation Mediators; Neural Stem Cells; Quality of Life; Stem Cell Transplantation; Pharmacology; Drug Discovery3003 Pharmaceutical Science; Clinical Biochemistry
English
2016
16
2
187
199
none
Mazzini, L., Vescovi, A., Cantello, R., Gelati, M., Vercelli, A. (2016). Stem cells therapy for ALS. EXPERT OPINION ON BIOLOGICAL THERAPY, 16(2), 187-199 [10.1517/14712598.2016.1116516].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/191624
Citazioni
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 22
Social impact